Skip to main content

ADVERTISEMENT

Martin Fleisch, MD

08/01/2008
The sizes of introducer sheaths and guiding catheters for percutaneous therapeutic interventions have decreased, which should reduce access-site complications.1–6 However, the use of novel antiplatelet drugs like glycoprotein IIb/IIIa...
The sizes of introducer sheaths and guiding catheters for percutaneous therapeutic interventions have decreased, which should reduce access-site complications.1–6 However, the use of novel antiplatelet drugs like glycoprotein IIb/IIIa...
The sizes of introducer sheaths...
08/01/2008
Journal of Invasive Cardiology